TetraQ’s daily operations are managed by the following team.
Professor Maree Smith
Executive Director
Expertise: Efficacy, Bioanalytics, Drug Metabolism, Pharmacokinetics
Professor Smith has a broad range of expertise in preclinical and clinical drug development, including animal models of human disease, bioanalytical method development and validation and in vivo pharmacokinetics in both animals and humans. Professor Smith is one of Australia's leading researchers in the pain field and has particular expertise in testing molecules of effectiveness as pain drugs. Professor Smith has considerable experience in commercialization of intellectual property which makes her well placed to understand the needs of early stage biopharmaceutical companies. Prof Smith is a member of the editorial board of Pain: Clinical Updates. She was awarded Honorary Fellowship of the Faculty of Pain Medicine, Australia and New Zealand College of Anaesthetists.
Dr. Bruce Wyse
Senior Manager Biological Services
Expertise: Efficacy, Toxicology
Bruce Wyse joined TetraQ at its inception after having completed 8 years of postdoctoral training (4 yrs in the USA followed by 4 yrs in Australia). Over the years, he has played a crucial role in the establishment and validation of animal models of human disease as well as cell lines to study the requirements necessary for G-protein coupled receptors to initiate signaling and how that signal may be maintained or altered. He has also been involved in ground-breaking research with regard to the identification and validation of potentially novel targets for new pain therapeutics.
Kris Dyszynski
VP Business Development, North America
Kris Dyszynski represents TetraQ and the Centre for Integrated Preclinical Drug Development (CIPDD) in North America. Mr. Dyszynski has over 25 years of business experience in the biotechnology industry, with global responsibilities. Prior to joining TetraQ/CIPDD, Mr. Dyszynski was based in the US as Vice President, Business Development for Australian biotechnology company Alchemia Limited.
Otto Damsma
Business Manager
Otto fulfilled several international management roles in the field of drug development. Notably, he has held the positions of Clinical Research Manager, Director of Clinical Data Management and Biostatistics and Director of Information Management for a major international pharmaceutical company over a period of 21 years and another 5 years in a business development role.
Simon Lake
Quality Assurance Manager
With a BSc (Hons) in Chemistry & MSc in Forensic Science, Simon Lake began his professional career with Glaxo Wellcome (now Glaxo SmithKline) where he worked as an Analytical Chemist in the UK. Having moved to Australia in 2006, Simon joined TetraQ as an Analyst & QA Representative for CIPDD/TetraQ ADME Bioanalytics before assuming the role of full-time Quality Assurance Manager for CIPDD/TetraQ in 2008.
QUICK LINKS